UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

Journal of bone and mineral research, 2008-12, Vol.23 (12), p.1923-1934

2008

Volltextzugriff (PDF)

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

Osteoporosis international, 2011-02, Vol.22 (2), p.567-576

2011

Volltextzugriff (PDF)

Fracture risk remains reduced one year after discontinuation of risedronate

Osteoporosis international, 2008-03, Vol.19 (3), p.365-372

2008

Volltextzugriff (PDF)

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Osteoporosis international, 2020, Vol.31 (1), p.181-191

2020

Volltextzugriff (PDF)

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Osteoporosis international, 2019-01, Vol.30 (1), p.71-78

2019

Volltextzugriff (PDF)

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Osteoporosis international, 2012, Vol.23 (1), p.351-363

2012

Volltextzugriff (PDF)

Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study

Journal of bone and mineral research, 2008-04, Vol.23 (4), p.525-535

2008

Volltextzugriff (PDF)

Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens

Menopause (New York, N.Y.), 2013-02, Vol.20 (2), p.138-145

2013

Volltextzugriff (PDF)

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

Calcified tissue international, 2004-12, Vol.75 (6), p.462-468

2004

Volltextzugriff (PDF)

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women

Climacteric : the journal of the International Menopause Society, 2013-06, Vol.16 (3), p.338-346

2013

Volltextzugriff (PDF)

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

The New England journal of medicine, 1997-08, Vol.337 (6), p.382-388

1997

Volltextzugriff (PDF)

Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate

Journal of bone and mineral research, 2003-06, Vol.18 (6), p.1051-1056

2003

Volltextzugriff (PDF)

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

Calcified tissue international, 2000-10, Vol.67 (4), p.277-285

2000

Volltextzugriff (PDF)

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

Osteoporosis international, 2019-09, Vol.30 (9), p.1855-1864

2019

Volltextzugriff (PDF)

An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX

Osteoporosis international, 2013-10, Vol.24 (10), p.2561-2569

2013

Volltextzugriff (PDF)

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis

BMC musculoskeletal disorders, 2010-06, Vol.11 (1), p.130-130, Article 130

2010

Volltextzugriff (PDF)

Adherence to treatment of osteoporosis : a need for study

Osteoporosis international, 2007-10, Vol.18 (10), p.1311-1317

2007

Volltextzugriff (PDF)

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

Journal of bone and mineral research, 2011-03, Vol.26 (3), p.519-529

2011

Volltextzugriff (PDF)

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease

Journal of bone and mineral research, 2022-08, Vol.37 (8), p.1437-1445

2022

Volltextzugriff (PDF)

Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial

The journal of clinical endocrinology and metabolism, 2014-02, Vol.99 (2), p.E189-E198

2014

Volltextzugriff (PDF)

A Bayesian path analysis to estimate causal effects of bazedoxifene acetate on incidence of vertebral fractures, either directly or through non-linear changes in bone mass density

Statistical methods in medical research, 2016-02, Vol.25 (1), p.400-412

2016

Volltextzugriff (PDF)

Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis

Therapeutic advances in musculoskeletal disease, 2012-02, Vol.4 (1), p.21-34

2012

Volltextzugriff (PDF)

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

The journal of clinical endocrinology and metabolism, 2001-05, Vol.86 (5), p.1890-1897

2001

Volltextzugriff (PDF)

The efficacy and safety of bazedoxifene in postmenopausal women by baseline kidney function status

Climacteric : the journal of the International Menopause Society, 2014-06, Vol.17 (3), p.273-284

2014

Volltextzugriff (PDF)

Efficacy and safety of bazedoxifene in postmenopausal Asian women

Osteoporosis international, 2011-02, Vol.22 (2), p.559-565

2011

Volltextzugriff (PDF)

1 – 25 von 425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(312)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(156)
Humans
(151)
Female
(98)
Middle Aged
(68)
Endocrinology & Metabolism
(67)
Aged
(59)
Male
(55)
Biological And Medical Sciences
(53)
Medical Sciences
(47)
Osteoporosis
(41)
Double-Blind Method
(34)
Adult
(32)
Osteoporosis, Postmenopausal - Drug Therapy
(30)
Physical Sciences
(30)
Genetics & Heredity
(29)
Aged, 80 And Over
(28)
Bone Density - Drug Effects
(26)
Orthopedics
(25)
Physics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(183)
Ingenta
(172)
MEDLINE
(158)
Journals@Ovid
(114)
Publisher or Other Site
(92)
IngentaConnect Journals
(58)
Elsevier ScienceDirect Journals Complete
(54)
SpringerLink_现刊
(47)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(38)
Oxford Journals
(37)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(35)
Wiley Online Library All Journals
(30)
Wiley Online Library
(27)
JSTOR
(25)
Oxford Journals 2020 Medicine
(18)
Ebook Central Perpetual and DDA
(15)
eBooks on EBSCOhost
(15)
Nature
(13)
AIP Journals Complete
(11)
Nexis Uni
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Wuli Xuebao
(20)
Bone
(16)
Journal Of Bone And Mineral Research
(15)
Osteoporosis International
(14)
Wuli Huaxue Xuebao
(14)
Perspectives Chinoises
(13)
The Journal Of Clinical Endocrinology And Metabolism
(12)
Diabetes
(11)
Review Of Scientific Instruments
(11)
Ye Jing Yu Xian Shi
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

Fracture risk remains reduced one year after discontinuation of risedronate

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study

Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis

Adherence to treatment of osteoporosis : a need for study

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease

Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial

A Bayesian path analysis to estimate causal effects of bazedoxifene acetate on incidence of vertebral fractures, either directly or through non-linear changes in bone mass density

Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

The efficacy and safety of bazedoxifene in postmenopausal women by baseline kidney function status

Efficacy and safety of bazedoxifene in postmenopausal Asian women

Suchergebnisse filtern